Alkem Laboratories Limited (ALKEM): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Alkem Laboratories Limited, explained in plain English.

• ▪Alkem Laboratories Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪ALKEM closed at ₹5,079.00 on 29 October 2026.
• ▪Over the past year the shares are down 8.2%, trading between ₹4,811.00 and ₹5,933.50.
• ▪Reported fundamentals show a net margin of 14.31%, debt to equity of 14.27.
• ▪Our transparent MaxGrade checklist scores it F (21/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 22.01% with a maximum drawdown of -16.01% and a beta of 0.69 against NIFTY 50.

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma, Biocon

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.